Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy

Hyun Pyo Hong, Tae-Seok Seo, In Ho Cha, Jung Rim Yu, Young Jae Mok, Joo Hyeong Oh, Se Hwan Kwon, Sam Soo Kim, Seung Kwon Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. Materials and Methods: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. Results: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84%). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90%). Infectious complications were noted in two patients (4%), and stent malfunction occurred in seven patients (14%). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). Conclusion: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure.

Original languageEnglish
Pages (from-to)789-796
Number of pages8
JournalKorean Journal of Radiology
Volume14
Issue number5
DOIs
Publication statusPublished - 2013 Sep 1

Fingerprint

Obstructive Jaundice
Gastrectomy
Stomach Neoplasms
Stents
Bilirubin
Self Expandable Metallic Stents
Survival
Serum
Drainage
Catheters

Keywords

  • Biliary tract
  • Gastric carcinoma
  • Interventional procedures
  • Malignant obstruction
  • Prosthesis
  • Stent

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. / Hong, Hyun Pyo; Seo, Tae-Seok; Cha, In Ho; Yu, Jung Rim; Mok, Young Jae; Oh, Joo Hyeong; Kwon, Se Hwan; Kim, Sam Soo; Kim, Seung Kwon.

In: Korean Journal of Radiology, Vol. 14, No. 5, 01.09.2013, p. 789-796.

Research output: Contribution to journalArticle

Hong, Hyun Pyo ; Seo, Tae-Seok ; Cha, In Ho ; Yu, Jung Rim ; Mok, Young Jae ; Oh, Joo Hyeong ; Kwon, Se Hwan ; Kim, Sam Soo ; Kim, Seung Kwon. / Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. In: Korean Journal of Radiology. 2013 ; Vol. 14, No. 5. pp. 789-796.
@article{4bd981dc36fb40319afa342ccb79af73,
title = "Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy",
abstract = "Objective: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. Materials and Methods: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. Results: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84{\%}). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90{\%}). Infectious complications were noted in two patients (4{\%}), and stent malfunction occurred in seven patients (14{\%}). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). Conclusion: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure.",
keywords = "Biliary tract, Gastric carcinoma, Interventional procedures, Malignant obstruction, Prosthesis, Stent",
author = "Hong, {Hyun Pyo} and Tae-Seok Seo and Cha, {In Ho} and Yu, {Jung Rim} and Mok, {Young Jae} and Oh, {Joo Hyeong} and Kwon, {Se Hwan} and Kim, {Sam Soo} and Kim, {Seung Kwon}",
year = "2013",
month = "9",
day = "1",
doi = "10.3348/kjr.2013.14.5.789",
language = "English",
volume = "14",
pages = "789--796",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "5",

}

TY - JOUR

T1 - Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy

AU - Hong, Hyun Pyo

AU - Seo, Tae-Seok

AU - Cha, In Ho

AU - Yu, Jung Rim

AU - Mok, Young Jae

AU - Oh, Joo Hyeong

AU - Kwon, Se Hwan

AU - Kim, Sam Soo

AU - Kim, Seung Kwon

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Objective: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. Materials and Methods: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. Results: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84%). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90%). Infectious complications were noted in two patients (4%), and stent malfunction occurred in seven patients (14%). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). Conclusion: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure.

AB - Objective: To evaluate the outcomes of patients undergoing percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. Materials and Methods: Fifty patients (mean age, 62.4 years; range, 27-86 years) who underwent percutaneous placements of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy were included. The technical success rate, clinical success rate, complication rate, stent patency, patient survival and factors associated with stent patency were being evaluated. Results: The median interval between the gastrectomy and stent placement was 23.1 months (range, 3.9-94.6 months). The 50 patients received a total of 65 stents without any major procedure-related complications. Technical success was achieved in all patients. The mean total serum bilirubin level, which had been 7.19 mg/dL ± 6.8 before stent insertion, decreased to 4.58 mg/dL ± 5.4 during the first week of follow-up (p < 0.001). Clinical success was achieved in 42 patients (84%). Percutaneous transhepatic biliary drainage catheters were removed from 45 patients (90%). Infectious complications were noted in two patients (4%), and stent malfunction occurred in seven patients (14%). The median stent patency was 233 ± 99 days, and the median patient survival was 179 ± 83 days. Total serum bilirubin level after stenting was an independent factor for stent patency (p = 0.009). Conclusion: Percutaneous transhepatic placement of a biliary stent for obstructive jaundice secondary to metastatic gastric cancer after gastrectomy is a technically feasible and clinically effective palliative procedure.

KW - Biliary tract

KW - Gastric carcinoma

KW - Interventional procedures

KW - Malignant obstruction

KW - Prosthesis

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=84883896687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883896687&partnerID=8YFLogxK

U2 - 10.3348/kjr.2013.14.5.789

DO - 10.3348/kjr.2013.14.5.789

M3 - Article

VL - 14

SP - 789

EP - 796

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

SN - 1229-6929

IS - 5

ER -